Document is current
Any future updates will be listed below
-
Authors
Logsdon, Derek P.
Shah, Fenil
Carta, Fabrizio
Supuran, Claudiu T.
Kamocka, Malgorzata
Jacobsen, Max H.
Sandusky, George E.
Kelley, Mark R.
Fishel, Melissa L. https://orcid.org/0000-0002-9436-6382
- License Information
-
More Information
Article History
Received: 15 June 2018
Accepted: 31 August 2018
First Online: 13 September 2018
Competing Interests
: Mark R. Kelley has licensed E3330 (APX3330) through Indiana University Research and Technology Corporation to Apexian Pharmaceuticals. Apexian Pharmaceuticals also provided APX2009 and APX2014. Apexian Pharmaceuticals had neither control nor oversight of the studies or the study design, results or interpretation, or presentation of the data in this manuscript. They did not have to approve the manuscript in any way prior to its submission. The other authors declare that they have no competing financial interests. The authors declare no non-financial competing interests.
